Bone marrow

System Immune/Lymphatic
SNOMED CT 421320006

Bone marrow

Definition

The soft tissue that fills the cavities of bones.

Also known as medulla ossea, medulla ossium — per UBERON

The Bone marrow is a part of the Immune/Lymphatic.

Also identified as

Associated Diseases

Disease Involvement Source
Fanconi anemia Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Fanconi anemia complementation group A Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Fanconi anemia complementation group B Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Fanconi anemia complementation group C Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Fanconi anemia complementation group D1 Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Fanconi anemia complementation group D2 Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Fanconi anemia complementation group E Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Fanconi anemia complementation group F Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Fanconi anemia complementation group G Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Fanconi anemia complementation group I Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Fanconi anemia complementation group J Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Hairy cell leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Hairy cell leukemia variant Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Hepatosplenic T-cell lymphoma Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Inherited acute myeloid leukemia Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Inherited acute myeloid leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Leukemia, myeloid, accelerated-phase Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Leukemia, myeloid, accelerated-phase Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Lymphoid leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Mast cell leukemia Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Mast cell leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Mixed phenotype acute leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Mixed phenotype acute leukemia, B/myeloid Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Mixed phenotype acute leukemia,T/myeloid Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Myelodysplastic syndrome Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Myelodysplastic syndrome Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Myelodysplastic syndrome associated with isolated del(5q) Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Myelodysplastic syndrome associated with isolated del(5q) Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Myelodysplastic syndrome with excess blasts Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Myelodysplastic syndrome with excess blasts Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Myelodysplastic syndrome with excess blasts-2 Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Myelodysplastic syndrome with excess blasts-2 Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Myelodysplastic syndrome with multilineage dysplasia Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Myelodysplastic syndrome with multilineage dysplasia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Myelodysplastic syndrome with single lineage dysplasia Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Myelodysplastic syndrome with single lineage dysplasia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Myelodysplastic/myeloproliferative neoplasm Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Myelodysplastic/myeloproliferative neoplasm Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Myelofibrosis Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Myeloid leukemia Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Myeloid leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Myeloid leukemia associated with down syndrome Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Myeloproliferative neoplasm Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Myeloproliferative neoplasm Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Myeloproliferative neoplasm, unclassifiable Disease Has Associated Anatomic Site NCIT · CC BY 4.0
Myeloproliferative neoplasm, unclassifiable Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Neonatal leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Plasma cell leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0
Precursor B-cell acute lymphoblastic leukemia Disease Has Primary Anatomic Site NCIT · CC BY 4.0

Showing 151–200 of 226

Drugs Acting Here

Drug Effect Source
Alemtuzumab may treat a disease of this organ DERIVED · CC BY 4.0
Anagrelide may treat a disease of this organ DERIVED · CC BY 4.0
Arsenic Trioxide may treat a disease of this organ DERIVED · CC BY 4.0
Asciminib may treat a disease of this organ DERIVED · CC BY 4.0
Azacitidine may treat a disease of this organ DERIVED · CC BY 4.0
Bendamustine may treat a disease of this organ DERIVED · CC BY 4.0
Blinatumomab may treat a disease of this organ DERIVED · CC BY 4.0
Busulfan may treat a disease of this organ DERIVED · CC BY 4.0
Chlorambucil may treat a disease of this organ DERIVED · CC BY 4.0
Cladribine may treat a disease of this organ DERIVED · CC BY 4.0
Clofarabine may treat a disease of this organ DERIVED · CC BY 4.0
Cyclophosphamide may treat a disease of this organ DERIVED · CC BY 4.0
Cytarabine may treat a disease of this organ DERIVED · CC BY 4.0
Dasatinib may treat a disease of this organ DERIVED · CC BY 4.0
Daunorubicin may treat a disease of this organ DERIVED · CC BY 4.0
Dexamethasone may treat a disease of this organ DERIVED · CC BY 4.0
Doxorubicin may treat a disease of this organ DERIVED · CC BY 4.0
Duvelisib may treat a disease of this organ DERIVED · CC BY 4.0
Enasidenib may treat a disease of this organ DERIVED · CC BY 4.0
Etoposide may treat a disease of this organ DERIVED · CC BY 4.0
Fedratinib may treat a disease of this organ DERIVED · CC BY 4.0
Fludarabine may treat a disease of this organ DERIVED · CC BY 4.0
Gemtuzumab Ozogamicin may treat a disease of this organ DERIVED · CC BY 4.0
Gilteritinib may treat a disease of this organ DERIVED · CC BY 4.0
Glasdegib may treat a disease of this organ DERIVED · CC BY 4.0
Hydroxyurea may treat a disease of this organ DERIVED · CC BY 4.0
Ibrutinib may treat a disease of this organ DERIVED · CC BY 4.0
Idarubicin may treat a disease of this organ DERIVED · CC BY 4.0
Idelalisib may treat a disease of this organ DERIVED · CC BY 4.0
Ifosfamide may treat a disease of this organ DERIVED · CC BY 4.0
Imatinib may treat a disease of this organ DERIVED · CC BY 4.0
Interferon Alfa-N3 may treat a disease of this organ DERIVED · CC BY 4.0
Interferon Beta-1B may treat a disease of this organ DERIVED · CC BY 4.0
Interferon Gamma-1b may treat a disease of this organ DERIVED · CC BY 4.0
Irinotecan may treat a disease of this organ DERIVED · CC BY 4.0
Isotretinoin may treat a disease of this organ DERIVED · CC BY 4.0
Ivosidenib may treat a disease of this organ DERIVED · CC BY 4.0
Mercaptopurine may treat a disease of this organ DERIVED · CC BY 4.0
Methotrexate may treat a disease of this organ DERIVED · CC BY 4.0
Methylprednisolone may treat a disease of this organ DERIVED · CC BY 4.0
Midostaurin may treat a disease of this organ DERIVED · CC BY 4.0
Mitoxantrone may treat a disease of this organ DERIVED · CC BY 4.0
Mogamulizumab may treat a disease of this organ DERIVED · CC BY 4.0
Momelotinib may treat a disease of this organ DERIVED · CC BY 4.0
Moxetumomab Pasudotox may treat a disease of this organ DERIVED · CC BY 4.0
Nilotinib may treat a disease of this organ DERIVED · CC BY 4.0
Obinutuzumab may treat a disease of this organ DERIVED · CC BY 4.0
Ofatumumab may treat a disease of this organ DERIVED · CC BY 4.0
Olutasidenib may treat a disease of this organ DERIVED · CC BY 4.0
Pacritinib may treat a disease of this organ DERIVED · CC BY 4.0

Showing 1–50 of 66

50 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.